SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The Board approved material compensatory arrangements for named executives and directors, including base salary increases retroactive to January 1, 2026 for the CEO, CFO, CAO, Controller, and other senior officers, as well as increases to annual equity target opportunities ranging from 75% to 400% of base salary and equity compensation for non-employee directors.
View raw filing on EDGAR →This exhibit is the 2026 Incentive Securities Plan adopted by Neo-Concept International Group Holdings Ltd on June 12, 2026. It establishes a comprehensive equity compensation framework allowing the Board to grant options, restricted share units, share appreciation rights, and restricted share awards to employees, directors, consultants, and sub-contractors. The plan reserves 472,856 shares for issuance and sets forth detailed terms for vesting, exercise, and performance criteria. This is a material disclosure of compensatory arrangements that would affect investor assessment of executive and employee incentive structures.
View raw filing on EDGAR →Stockholders approved an amendment and restatement of the 2021 Stock Incentive Plan, which affects equity grants and awards across the company. A director reclassification (Curran's transition from Class II to Class III) was also disclosed but is administrative in nature.
View raw filing on EDGAR →The filing discloses Board approval of base salary ($300,000) and target bonus (40% of base salary) for Ross Ridenoure, Chief Nuclear Officer, following the company's business combination closing. This is a compensatory arrangement disclosure under Item 5.02(e), establishing initial compensation terms for an executive officer in his post-closing role. The materiality reflects that executive compensation arrangements are material to investors assessing management incentives and cost structure.
View raw filing on EDGAR →The filing discloses retention bonus letter agreements entered into on June 10, 2026 with two named executives: Nelson Sun (CFO/COO) receiving $346,500 and Dr. Manasi Jaiman (CMO) receiving $357,000. These are compensatory arrangements—guaranteed annual bonuses and retention bonuses—payable contingent on continued employment or qualifying termination events, which is the hallmark of exec_compensation disclosures under Item 5.02(e).
View raw filing on EDGAR →The filing centers on the grant of performance-based stock option awards to Mitchell P. Rales, Shyam P. Kambeyanda, and other senior management team members. While the section also discloses Rales' appointment as Executive Chair and Jordan's appointment as Lead Independent Director, the substantive disclosure focuses on the design, terms, and vesting conditions of the compensatory arrangements—including stock price hurdles, service vesting periods, and share counts. This is a classic exec_compensation event under Item 5.02(e), material to investors assessing executive incentive alignment and retention strategy.
View raw filing on EDGAR →SAGTEC Global Limited granted supplemental equity-based compensation to three named executive officers in May 2026: CEO Ng Chen Lok (415,000 restricted Class A Ordinary Shares valued at ~USD 387,609), Group CFO Zuria Hajar Binti Mohd Adnan (15,000 shares valued at ~USD 14,001), and CTO Tan Kim Chuan (50,000 shares valued at ~USD 46,700) for 2026 services.
View raw filing on EDGAR →The company approved the 2026 Executive Compensation Plan on February 26, 2026, increasing base salaries by 5% for CEO Steven M. Foster ($420,000), CFO Kevin Williamson ($330,750), and COO Richard Ginn ($304,500), and modified annual bonus opportunities. Additionally, the company amended Richard Ferrari's consulting agreement as Executive Chairman, extending his term through May 6, 2027 at $180,000 annually.
View raw filing on EDGAR →The disclosure centers on a material change to Ms. Conn's compensation arrangement as CFO: her transition to part-time status effective June 29, 2026, with a corresponding salary adjustment to reflect her reduced work schedule. While the filing is captioned Item 5.02 (which covers departures, appointments, and compensation), the principal action disclosed is a compensatory arrangement modification rather than a departure (she remains CFO) or appointment (no new officer is being named). The salary adjustment tied to the role change is the material event.
View raw filing on EDGAR →The filing discloses Board approval of the 2026 Equity Incentive Plan and grants of stock options to named executive officers (Carlos X. Montoya, Ken Park, Brad Hoffman, John Jubilee, and Patrick White) and other employees/service providers. The disclosure details vesting schedules, performance conditions, and exercise prices for equity awards, which constitutes a compensatory arrangement under Item 5.02(e). This is material as it affects executive compensation structure and potential dilution to shareholders.
View raw filing on EDGAR →Avalo Therapeutics amended employment agreements for four named executives (CEO Dr. Neil, CFO Sullivan, CMO Dr. Doyle, and CBO Boyd) to modify severance, change-of-control payments, equity acceleration, and 280G tax gross-up provisions.
View raw filing on EDGAR →The disclosure centers on Amendment No. 1 to Danny Rittman's employment agreement as CTO/CISO, which modifies his compensation through: (1) a base salary increase to $180,000 effective June 1, 2026; and (2) a grant of 1,000,000 performance-based stock options at $4.98/share with milestone-based vesting tied to technical deliverables (VisionRF data room, StratumAI agent release, cybersecurity framework, and EDA strategy room). While the title update is noted, the substantive disclosure is compensatory in nature—salary adjustment and equity grant—making this an exec_compensation event rather than appointment or departure.
View raw filing on EDGAR →The filing discloses equity option grants to named executives and directors under the 2021 Incentive Stock Plan. Ian Bothwell (CEO/CFO), George Shapiro (Chief Medical Officer), and non-executive director Chuck Bretz each received option awards totaling 625,000 to 1,250,000 shares at $1.67 per share. This is a compensatory arrangement for officers and directors, the core subject matter of Item 5.02(e), and materially affects executive compensation structure.
View raw filing on EDGAR →Universal Health Realty Income Trust granted restricted stock awards to four named executive officers on June 10, 2026, with specified share quantities and vesting terms as part of the company's annual long-term incentive compensation program.
View raw filing on EDGAR →The filing's primary focus is the approval of cash retention payments and amended "Change in Control" benefits for named executives (Sapir, Oltmans, Musso) in connection with a restructuring plan following discontinuation of pociredir development. While the section also discloses Greg Tourangeau's departure, the bulk of the disclosure centers on compensatory arrangements—retention bonuses and severance modifications—approved by the compensation committee and board, making exec_compensation the most salient event type.
View raw filing on EDGAR →The filing's principal disclosure under Item 5.02 is an Amended and Restated Compensation Agreement with CEO Kevin O'Donnell, effective June 5, 2026. The agreement specifies a $550,000 annual base salary, a one-time $875,000 cash bonus, elimination of future annual bonus opportunities, and detailed severance and termination provisions. This is a material compensatory arrangement modification for a named executive officer that would affect investor assessment of executive pay and retention incentives.
View raw filing on EDGAR →Shareholders approved the Fifth Amended and Restated 2019 Equity Incentive Plan, increasing authorized shares by 565,000 for equity compensation purposes to officers and directors.
View raw filing on EDGAR →The filing discloses amendments to compensatory arrangements for two named executives: Lachlan K. Murdoch (Executive Chair and CEO) and Steven Tomsic (CFO). The Committee and Board approved increases in target annual bonuses and equity awards for both executives, as well as extensions of their employment terms through June 30, 2030. This is a classic executive compensation disclosure under Item 5.02(e), distinct from a departure or appointment, and is material to investors assessing executive incentive structures and retention.
View raw filing on EDGAR →Stockholders approved an Amended and Restated 2014 Employee Stock Purchase Plan (ESPP) with an increase of 800,000 newly reserved shares, a material compensatory arrangement affecting equity incentives available to employees.
View raw filing on EDGAR →Shareholders approved an amended and restated 2023 Incentive Award Plan that increases shares reserved for issuance by 16.5 million shares and modifies tax withholding provisions, directly affecting equity grant structures for officers and directors.
View raw filing on EDGAR →The Compensation Committee approved a $90,000 cash increase in annual compensation for Jeffrey D. Yowell, the Executive Chairman, effective June 1, 2026, bringing his total annual compensation to $340,000. This is a direct disclosure of a compensatory arrangement modification for a named executive officer, which falls squarely within the exec_compensation category. The materiality is supported by the magnitude of the increase and the fact that it was formally approved by the Committee.
View raw filing on EDGAR →Shareholders approved and the Board adopted the 2026 Equity Incentive Plan, which amends the existing Omnibus Equity Incentive Plan and establishes the framework for future equity compensation grants to officers and directors, effective June 4, 2026.
View raw filing on EDGAR →The Compensation Committee approved a performance-based cash bonus for CFO Michael Graham O'Brien with a target award value of $500,000, contingent on fiscal year 2026 adjusted operating income goals. This is a direct disclosure of a compensatory arrangement for a named executive officer, fitting the exec_compensation category. The materiality threshold is met given the significant dollar amount and the CFO's role.
View raw filing on EDGAR →The disclosure centers on approval of a special restricted stock unit award with a grant date fair value of $600,000 to Stuart A. Randle, the Interim President and Chief Executive Officer. This is a compensatory arrangement for a named executive officer, approved by the Board's Compensation Committee, and falls squarely within the exec_compensation category. The materiality is clear given the substantial dollar amount and the executive's role as interim CEO.
View raw filing on EDGAR →The Compensation Committee approved increases to Deborah Andrews' annual base salary (from $512,000 to $575,000) and target annual cash bonus (from 55% to 60% of base salary), effective June 8, 2026. This is a direct disclosure of compensatory arrangements for a named executive officer, fitting the exec_compensation category. The adjustments are material as they represent a meaningful increase in total compensation for a senior officer (Interim Co-CEO and CFO).
View raw filing on EDGAR →The Board approved compensatory arrangements for the five named executive officers, including 2026 fiscal year annual incentive payouts (161% of target), 2027 long-term equity incentive awards (RSUs and PSUs with ROIC and EBITDA performance goals), 2027 annual incentive plan structure, and 2027 base salary approvals.
View raw filing on EDGAR →The Board adopted three new forms of equity award agreements (Performance RSA Agreement, Time-based RSA Agreement, and RSU Award Agreement) under the 2020 LTIP on June 4, 2026, and the Compensation Committee awarded restricted shares to executive officers and directors pursuant to these agreements. This disclosure centers on compensatory arrangements—the establishment of new equity award forms and their grant to named executives and directors—which is the hallmark of Item 5.02(e) compensation disclosures.
View raw filing on EDGAR →The filing discloses an amended and restated employment agreement for Ms. Cindy Lee, the Chief Financial Officer, detailing her base salary ($500,000), discretionary bonus eligibility, a special long-term equity award of 20,000 RSUs vesting over three years, severance provisions including change-of-control protections (2.5x base salary plus bonus), and benefits continuation. This is a material compensatory arrangement for a named executive officer that would affect investor assessment of executive costs and retention incentives.
View raw filing on EDGAR →Stockholders approved the 2026 Incentive Award Plan, which replaces the prior equity compensation plan and authorizes 5,001,201 shares for future grants of stock options, RSUs, restricted stock, and other equity awards to employees, consultants, and directors.
View raw filing on EDGAR →The Compensation Committee approved adoption of a new Executive Severance and Change in Control Plan effective June 5, 2026, which establishes severance and change-in-control benefits for named executive officers and other key employees. This is a compensatory arrangement disclosure under Item 5.02(e), distinct from an executive departure or appointment. The plan specifies tiered severance payments, equity acceleration, and COBRA benefits triggered by qualifying termination events, making it material to investor assessment of executive compensation obligations.
View raw filing on EDGAR →Rain Enhancement Technologies issued 50,000 shares of Class A Common Stock to interim CFO Oanh Truong as compensation for services pursuant to the 2024 Equity Incentive Plan.
View raw filing on EDGAR →Rain Enhancement Technologies issued 490,000 shares of Class A Common Stock as deferred compensation to six directors (Dickerson, Steele, Reardon, Peperzak, Riley, Sylvester), a Senior Technology Advisor (Morris), and an independent contractor (Monroe) pursuant to the 2024 Equity Incentive Plan and previously-disclosed Director Agreements.
View raw filing on EDGAR →The filing discloses modifications to compensatory arrangements for two named executives—Jose Vargas (Head of Business Development and board member) and Theodore Rosenthal (President of Digital Assets Division)—reducing their annual base salaries from $150,000 to $30,000 per annum effective May 11, 2026. This is a material change to executive compensation reflecting the Company's reduced scale of operations, disclosed under Item 5.02(e).
View raw filing on EDGAR →The Board approved revisions to the Amended and Restated Non-Employee Director Compensation Program, which establishes annual cash and equity compensation arrangements for non-employee directors.
View raw filing on EDGAR →Semtech amended its Executive Severance Plan to expand severance benefits to cover terminations outside a Change in Control, and amended the 2017 Long-Term Equity Incentive Plan to increase available shares by 4.3 million.
View raw filing on EDGAR →The Board approved a form of restricted stock unit agreement for annual equity awards to non-employee directors under the Company's Equity Incentive Plan, establishing vesting terms (first anniversary with continuous service requirement) and director equity compensation arrangements.
View raw filing on EDGAR →The filing discloses approval by the Compensation Committee of performance-based restricted stock unit (PBRSU) awards for fiscal year 2027 to named executive officers, including CEO Robert Bruggeworth and CFO Grant Brown, along with a specific retention award to Philip Chesley. These are compensatory arrangements subject to performance and service conditions, directly falling under Item 5.02(e) disclosure requirements. The disclosure includes target grant values, performance metrics, and vesting conditions—all hallmarks of executive compensation arrangements material to investor assessment.
View raw filing on EDGAR →The filing discloses amended and restated employment agreements for three named executives (William Santana Li, Apoorv S. Dwivedi, and Mercedes Soria) that establish new base salaries, annual bonus targets, performance-based cash awards with aggregate target values of $65M, $35.75M, and $22.75M respectively, severance arrangements, and stock option grants. This is a comprehensive compensatory arrangement disclosure under Item 5.02(e), distinct from an appointment or departure, and materially affects investor assessment of executive incentives and potential future obligations.
View raw filing on EDGAR →The board awarded success bonuses totaling $450,000 to four named executive officers (Douglas Kaye, David Johnson, Timothy Donnelly, and Shirin Khosravi) in recognition of their role in restructuring the Company's debt.
View raw filing on EDGAR →Equity Residential disclosed compensatory arrangements for four named executives (Schall, Manelis, O'Shea, and Fenster) in connection with the pending Equity Residential–AvalonBay merger, including base salaries, cash and equity incentive targets, long-term performance-vesting awards, and one-time transaction awards.
View raw filing on EDGAR →The Board and stockholders approved and adopted the 2026 Omnibus Incentive Plan and the 2026 Employee Stock Purchase Plan, both effective June 3, 2026, establishing the company's post-IPO equity compensation framework.
View raw filing on EDGAR →Stockholders approved the Smart Sand, Inc. 2026 Equity Incentive Plan and 2026 Employee Stock Purchase Plan on June 2, 2026, authorizing 2,400,000 new shares under the equity plan and 3,000,000 shares for the ESPP, along with forms of award agreements for restricted stock awards.
View raw filing on EDGAR →CEO Vijay Kotte entered into a Cash Performance Plan Award Agreement establishing a multi-tranche cash performance award with specified measurement dates and performance goals, including an initial payment of approximately $2.87 million already earned, with vesting conditions and forfeiture provisions.
View raw filing on EDGAR →The Board adopted a revised Director Compensation Policy effective June 4, 2026, modifying the structure of director compensation by splitting RSU awards equally between restricted stock units and a long-term cash award to reduce dilution.
View raw filing on EDGAR →The Board approved grants of 7,000,000 restricted shares to four executives and directors (Silverman, Bernstein, Boctor, and Walker) with a two-tranche vesting schedule (50% immediate, 50% at six months). This is a compensatory arrangement for named executives and directors, clearly falling under Item 5.02(e) disclosure of equity grants. The aggregate size and broad distribution to senior leadership makes this material to investors.
View raw filing on EDGAR →The Board approved an Employee Retention Program providing cash-based retention awards and nonqualified stock option grants to named executive officers, including CEO Douglas W. Campbell ($1.2M cash plus 190,600 options), CFO Jonathan Collins ($563K cash plus 45,380 options), COO Jamie Fischer ($531K cash plus 50,660 options), and Chief Accounting Officer Vickie D. Judy ($300K cash plus 16,336 options).
View raw filing on EDGAR →The disclosure centers on the Board's approval and grant of 4,060,000 performance share units to Daniel Tassé, the CEO, pursuant to the newly adopted DBV Technologies 2026 Performance Share Unit Plan. This is a compensatory arrangement for a named executive officer involving equity grants with performance and employment conditions, which is the core subject matter of Item 5.02(e). While the filing also references shareholder authorization and plan adoption, the principal disclosed action is the grant of PSUs to the CEO, making this an executive compensation event that would materially affect investor assessment of the company's incentive structure and CEO alignment.
View raw filing on EDGAR →The Board approved base salaries and target bonuses for four named executive officers (CEO, CFO, CTO, COO) following the company's business combination closing. This is a compensatory arrangement disclosure under Item 5.02(e), establishing initial compensation structures with specific salary amounts and bonus percentages. The disclosure is material as it establishes executive compensation post-merger and would affect investor assessment of the company's cost structure and executive incentives.
View raw filing on EDGAR →The filing discloses compensatory arrangements for named executive officers and non-employee directors, including: (1) renewal and amendment of the Annual Long-Term Incentive Award Plan with specific RSU and PSU grants to Matthew Malone, Daniel J. Thoren, and Christopher J. Thome; (2) amendment of the Annual Executive Cash Bonus Program with target bonus levels ranging from 50% to 100% of base salary; and (3) annual RSU grants to six non-employee directors. These are classic executive compensation disclosures under Item 5.02(e), material to investors assessing executive incentive structures and equity dilution.
View raw filing on EDGAR →The filing discloses awards of Restricted Stock Units (RSUs) to three named executive officers—David A. Hedges (2,078 RSUs), W. James Walker, IV (1,207 RSUs), and Robert L. Smith (1,190 RSUs)—approved by the Compensation Committee on June 5, 2026 under the Company's 2024 Equity and Incentive Compensation Plan. This is a compensatory arrangement for named executives involving equity grants with specified vesting schedules and terms, which is the core definition of exec_compensation under Item 5.02(e).
View raw filing on EDGAR →